Clinical Trial Update: Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of CPGJ602 with chemotherapy as first-line treatment for metastatic colorectal cancer with wild KRAS/NRAS/BR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CPGJ602

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN